| Literature DB >> 30699302 |
Leonie Schnell1, Ina Felix1, Bastian Müller1, Mirko Sadi1, Franziska von Bank1, Panagiotis Papatheodorou1, Michel R Popoff2, Klaus Aktories3, Eva Waltenberger4, Roland Benz4, Conrad Weichbrodt5, Michael Fauler6, Manfred Frick6, Holger Barth1.
Abstract
The antibiotic bacitracin (Bac) inhibits cell wall synthesis of gram-positive bacteria. Here, we discovered a totally different activity of Bac: the neutralization of bacterial exotoxins. Bac prevented intoxication of mammalian cells with the binary enterotoxins Clostridium botulinum C2, C. perfringens ι, C. difficile transferase (CDT), and Bacillus anthracis lethal toxin. The transport (B) subunits of these toxins deliver their respective enzyme (A) subunits into cells. Following endocytosis, the B subunits form pores in membranes of endosomes, which mediate translocation of the A subunits into the cytosol. Bac inhibited formation of such B pores in lipid bilayers in vitro and in living cells, thereby preventing translocation of the A subunit into the cytosol. Bac preserved the epithelial integrity of toxin-treated CaCo-2 monolayers, a model for the human gut epithelium. In conclusion, Bac should be discussed as a therapeutic option against infections with medically relevant toxin-producing bacteria, including C. difficile and B. anthracis, because it inhibits bacterial growth and neutralizes the secreted toxins.-Schnell, L., Felix, I., Müller, B., Sadi, M., von Bank, F., Papatheodorou, P., Popoff, M. R., Aktories, K., Waltenberger, E., Benz, R., Weichbrodt, C., Fauler, M., Frick, M., Barth, H. Revisiting an old antibiotic: bacitracin neutralizes binary bacterial toxins and protects cells from intoxication.Entities:
Keywords: anthrax toxin; bacterial binary AB-toxins; toxin inhibitor
Mesh:
Substances:
Year: 2019 PMID: 30699302 DOI: 10.1096/fj.201802453R
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191